John C. Roche, President and CEO of Hanover Insurance Group, Inc., filed a Form 4 on November 13, 2026, disclosing a series of stock option exercises and open-market sales of common stock on November 11 and 12, 2026.
Key Highlights
- Two options net exercised: Roche exercised options covering 48,052 shares at $104.11 and 36,539 shares at $117.22, both on November 11, 2026, using a net-exercise method.
- Shares withheld for exercise costs and taxes: According to the filing, 60,198 shares were withheld by the company to cover the exercise price and associated taxes, resulting in a net issuance of 24,393 shares.
- Open-market sales on November 12: Roche sold 1,100 shares at a weighted average price of $247.9327, 10,393 shares at $249.3673, and 2,929 shares at $249.9971.
- Remaining direct ownership: Following all reported transactions, Roche directly held 151,224.034 shares of common stock, not including 14,454 shares held by his spouse.
- Options fully exhausted: Both exercised options now show zero derivative securities remaining, per Table II of the filing.
Roche's Option Exercises and Share Sales at Hanover Insurance Group
According to the Form 4 filed with the SEC on November 13, 2026, John C. Roche, who serves as President and CEO and also as a director of Hanover Insurance Group, Inc. (NYSE:THG), reported multiple transactions in the company's common stock over two consecutive trading days. On November 11, 2026, Roche net exercised two tranches of stock options. The first covered 48,052 shares with an exercise price of $104.11, and the second covered 36,539 shares with an exercise price of $117.22. The filing states that the options were "net exercised," meaning 60,198 shares were withheld by the company to satisfy both the exercise price and applicable taxes, yielding a net issuance of 24,393 shares.
The filing shows that the first option originally represented the right to purchase a total of 72,078 shares, with vesting occurring in thirds on February 27, 2019, 2020, and 2021, and an expiration date of February 27, 2028. The second option represented the right to purchase a total of 36,539 shares, vesting in thirds on March 5, 2020, 2021, and 2022, with an expiration date of March 5, 2029. Following the exercises, both options reflect zero remaining derivative securities.
On November 12, 2026, Roche sold shares in three separate transactions. The filing reports weighted average sale prices of $247.9327 for 1,100 shares, $249.3673 for 10,393 shares, and $249.9971 for 2,929 shares. Each weighted average represents sales executed across a price range, and the filing notes that full price-by-price detail is available upon request to THG, any THG security holder, or SEC staff. After all reported activity, Roche's direct beneficial ownership stood at 151,224.034 shares.
What Was Disclosed
The filing disclosed net exercises of two stock option grants and three open-market common stock sales by Roche on November 11 and 12, 2026, with his direct beneficial ownership in Hanover Insurance Group reduced to 151,224.034 shares following all transactions.



Please wait processing your request...